Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

Market Cap	29.93M
Revenue (ttm)	17.68M
Net Income (ttm)	3.38M
Shares Out	9.50M
EPS (ttm)	0.36
PE Ratio	8.87
Forward PE	n/a
Dividend	0.22 (6.98%)
Ex-Dividend Date	Apr 10, 2025

Volume	50
Average Volume	833
Open	3.150
Previous Close	n/a
Day's Range	3.150 - 3.150
52-Week Range	2.450 - 3.150
Beta	0.03
RSI	63.37
Earnings Date	Oct 29, 2025

About ASE:HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 234
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2024, ASE:HPIC's revenue was 16.71 million, an increase of 5.72% compared to the previous year's 15.81 million. Earnings were 3.09 million, an increase of 32.73%.